Page 54 - Michael Erman News Today

By Michael Erman (Reuters) - Merck & Co posted better-than-expected first-quarter earnings and raised its full-year sales estimate on strength from it...

By Michael Erman and Julie Steenhuysen (Reuters) - Moderna Inc said on Thursday it asked U.S. regulators to authorize its COVID-19 vaccine for childre...

By Michael Erman and Julie Steenhuysen (Reuters) - Moderna Inc said on Thursday it asked U.S. regulators to authorize its COVID-19 vaccine for childre...

By Michael Erman and Julie Steenhuysen (Reuters) - Moderna Inc said on Thursday it asked U.S. regulators to authorize its COVID-19 vaccine for childre...

(Reuters) - Moderna Inc said on Thursday it asked U.S. regulators to authorize its COVID-19 vaccine for childr...

By Michael Erman and Julie Steenhuysen (Reuters) - Moderna Inc said on Thursday it asked U.S. regulators to authorize its COVID-19 vaccine for childre...

By Michael Erman and Julie Steenhuysen (Reuters) - Moderna Inc said on Thursday it asked U.S. regulators to authorize its COVID-19 vaccine for childre...

By Michael Erman (Reuters) - Worldwide demand for Pfizer Inc's oral COVID-19 antiviral treatment Paxlovid has been unexpectedly light due to complicat...

NEW YORK (Reuters) - Pfizer Chief Executive Albert Bourla said on Wednesday that the company could possibly develop a new vaccine that protects agains...

By Manas Mishra and Michael Erman (Reuters) - The U.S. Food and Drug Administration said it is aiming to come up with a decision on coronavirus strain